Executive equity grants and tax withholdings at TELA Bio (NASDAQ: TELA) detailed
Rhea-AI Filing Summary
TELA Bio, Inc. Chief Business Officer Gregory A. Firestone reported a mix of equity grants and tax-related share dispositions. On February 20, 2026, he was granted 55,000 stock options and 37,000 shares of common stock in the form of restricted stock units that vest in four equal annual installments beginning February 20, 2027, subject to his continued service. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments over the next 36 months, also conditioned on continued service. On February 21 and 23, 2026, a total of 5,541 common shares were withheld by the company at prices of $0.7174 and $0.7660 per share to satisfy tax liabilities upon RSU vesting, leaving him with 139,307 common shares held directly, which includes 1,058 shares acquired under the employee stock purchase plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,352 | $0.766 | $1K |
| Tax Withholding | Common Stock | 4,189 | $0.7174 | $3K |
| Grant/Award | Stock Option (Right to Buy) | 55,000 | $0.00 | -- |
| Grant/Award | Common Stock | 37,000 | $0.00 | -- |
Footnotes (1)
- These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Includes 1,058 shares acquired under the Company's employee stock purchase plan on January 30, 2026. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.